Pipeline

7TM Pharma has a pipeline of discovery and development programs based on in-house research and development. The pipeline combines peptide and small molecule programs and includes two clinical programs both targeting the treatment of obesity, an indication within 7TM Pharmas focus on metabolic disorders. Additional drug discovery programs focus on novel treatments for inflammation (asthma/allergy), vascular diseases and metabolic disorders.

Further drug targets are continuously being biologically and chemically validated to fuel and grow the pipeline from our core capacities. 7TM Pharma expects to select at least 2-3 additional pre-clinical development candidates from its discovery activities to move into clinical development within the next few years.